☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
HIV-1 Infection
ViiV's Vocabria (cabotegravir- tablet formulation) Receives the US FDA's Approval for the Treatment of HIV-1 infection
January 22, 2021
Gilead's Biktarvy (Bictegravir- Emtricitabine and Tenofovir Alafenamide) Receives NMPA's Approval for Treatment of HIV-1 Infection
August 12, 2019
ViiV Healthcare Reports Submission of MAA to EMA for the Combination of Cabotegravir + Rilpivirine to Treat HIV-1 Infection
July 29, 2019
ViiV Healthcare Reports Results of Fostemsavir in P-III BRIGHTE Study for HIV-1 infection
July 23, 2019
ViiV Healthcare Reports Results of Dual-Drug Regimen in P-III TANGO Study for HIV-1 Infection
July 10, 2019
ViiV Healthcare Files NDA for Cabotegravir + Edurant (rilpivirine) to the US FDA to Treat HIV-1 Infection in Adults
April 30, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.